4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid
C26H19Cl2FN2O4S — CID 15947594
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid
4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid (PubChem CID 15947594) has the molecular formula C26H19Cl2FN2O4S and a molecular weight of 545.42 g/mol. Its IUPAC name is 4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid.
Molecular Properties
| Compound Name | 4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid |
|---|---|
| PubChem CID | 15947594 |
| Molecular Formula | C26H19Cl2FN2O4S |
| Molecular Weight | 545.42 g/mol |
| Exact Mass | 544.04 |
| IUPAC Name | 4-[3-chloro-4-[2-(2-chloro-6-fluorophenyl)-4-prop-1-en-2-ylimidazol-1-yl]phenyl]-2-methylsulfonylbenzoic acid |
| SMILES | C=C(C)c1cn(-c2ccc(-c3ccc(C(=O)O)c(S(C)(=O)=O)c3)cc2Cl)c(-c2c(F)cccc2Cl)n1 |
| InChI | InChI=1S/C26H19Cl2FN2O4S/c1-14(2)21-13-31(25(30-21)24-18(27)5-4-6-20(24)29)22-10-8-15(11-19(22)28)16-7-9-17(26(32)33)23(12-16)36(3,34)35/h4-13H,1H2,2-3H3,(H,32,33) |
| InChIKey | LMIZJHFXGRUVLE-UHFFFAOYSA-N |
| XLogP | 6.79 |
| TPSA | 89.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 545.42 |
| LogP ≤ 5 | 6.79 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15947594 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.